Variability of blood glucose concentration and short-term mortality in critically ill patients

Anesthesiology

Volumn 105, Issue 2, 2006, Pages 244-252

  Egi, Moritoki ^a   Bellomo, Rinaldo ^a,d   Stachowski, Edward ^b   French, Craig J ^c   Hart, Graeme ^a  

^a AUSTIN HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c Western Hospital   (Australia)

^d AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CALCULATION; CLINICAL FEATURE; COHORT ANALYSIS; CRITICALLY ILL PATIENT; DATA BASE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTENSIVE CARE UNIT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT CODING; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; CRITICAL CARE; CRITICAL ILLNESS; DIABETES MELLITUS; FEMALE; FORECASTING; HOSPITAL MORTALITY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LOGISTIC MODELS; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; ROC CURVE; SURVIVAL ANALYSIS;

EID: 33746621650     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200608000-00006     Document Type: Article

References (34)

1. Wolfe RR, Allsop JR, Burke JF: Glucose metabolism in man: Responses to intravenous glucose infusion. Metabolism 1979; 28:210-20
2. Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Herndon DN, Wolfe RR: Differentiation between septic and postburn insulin resistance. Metabolism 1989; 38:983-9
3. Robinson LE, van Soeren MH: Insulin resistance and hyperglycemia in critical illness: Role of insulin in glycemic control. AACN Clin Issues 2004; 15:45-62
4. Coursin DB, Connery LE, Ketzler JT: Perioperative diabetic and hyperglycemic management issues. Crit Care Med 2004; 32:S116-25
5. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year. J Am Coll Cardiol 1995; 26:57-65
6. Malmberg K: Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 1997; 314:1512-5
7. Ouattara A, Lecomte P, Le Manach Y, Landi M, Jacqueminet S, Platonov I, Bonnet N, Riou B, Coriat P: Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. ANESTHESIOLOGY 2005; 103:687-94
8. Kersten JR, Warltier DC, Pagel PS: Aggressive control of intraoperative blood glucose concentration: A shifting paradigm? ANESTHESIOLOGY 2005; 103:677-8
9. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-67
10. Leow MK, Wyckoff J. Under-recognised paradox of neuropathy from rapid glycaemic control. Postgrad Med J 2005; 81:103-7
11. Krinsley JS: Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004; 79:992-1000
12. Christiansen C, Toft P, Jorgensen HS, Andersen SK, Tonnesen E: Hyperglycaemia and mortality in critically ill patients: A prospective study. Intensive Care Med 2004; 30:1685-8
13. Bolk J, van der Ploeg T, Cornel JH, Arnold AE, Sepers J, Umans VA: Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 2001; 79:207-14
14. Lanzino G, Kassell NF, Germanson T, Truskowski L, Alves W: Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 1993; 79:885-91
15. Margulies DR, Hiatt JR, Vinson D Jr, Shabot MM: Relationship of hyperglycemia and severity of illness to neurologic outcome in head injury patients. Am Surg 1994; 60:387-90
16. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, Markiewicz W, Aronson D: Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: A prospective study. Circulation 2005; 111:754-60
17. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-29
18. van der Horst IC, Gans RO, Nijsten MW, Ligtenberg JJ: Beneficial effect of glucose-insulin-potassium infusion in noncritically ill patients has to be proven. J Intern Med 2003; 254:513-4
19. Schricker T, Gougeon R, Eberhart L, Wykes L, Mazza L, Carvalho G, Carli F: Type 2 diabetes mellitus and the catabolic response to surgery. ANESTHESIOLOGY 2005; 102:320-6
20. Amour J, David JS, Vivien B, Coriat P, Riou B: Interaction of halogenated anesthetics with α- and β-adrenoceptor stimulations in diabetic rat myocardium. ANESTHESIOLOGY 2004; 101:1145-52
21. Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-7
22. Grey NJ, Perdrizet GA: Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004;10 (suppl 2):46-52
23. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, Macleod K, Laakso M, Torp-Pedersen C, Waldenstrom A: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): Effects on mortality and morbidity. Eur Heart J 2005; 26:650-61
24. Lynch M, Gammage MD, Lamb P, Nattrass M, Pentecost BL: Acute myocardial infarction in diabetic patients in the thrombolytic era. Diabet Med 1994; 11:162-5
25. Leor J, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Behar S: Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: Incidence, risk factors, and outcome. SPRINT Study Group. Am J Med 1993; 94:265-73
26. O'Sullivan JJ, Conroy RM, Robinson K, Hickey N, Mulcahy R: In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991; 14:758-60
27. Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 2000; 355:773-8
28. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A: Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-60; discussion 360-2
29. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 125:1007-21
30. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M: Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001; 51:540-4
31. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC: Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004; 56:1058-62
32. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-61
33. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295:1681-7
34. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-66